PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 201 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,234,000 | +8.3% | 124,200 | -57.1% | 0.01% | -14.3% |
| Q1 2020 | $2,063,000 | -66.4% | 289,336 | +12.5% | 0.01% | -53.3% |
| Q4 2019 | $6,140,000 | +40.6% | 257,136 | +57.9% | 0.02% | +25.0% |
| Q3 2019 | $4,368,000 | +23.1% | 162,879 | +24.6% | 0.01% | +20.0% |
| Q2 2019 | $3,547,000 | -8.7% | 130,760 | +16.8% | 0.01% | -9.1% |
| Q1 2019 | $3,883,000 | +119.5% | 111,910 | +23.5% | 0.01% | +83.3% |
| Q4 2018 | $1,769,000 | -25.1% | 90,610 | +2.2% | 0.01% | -14.3% |
| Q3 2018 | $2,362,000 | -5.8% | 88,700 | +33.6% | 0.01% | 0.0% |
| Q2 2018 | $2,508,000 | +51.5% | 66,400 | +31.1% | 0.01% | +40.0% |
| Q1 2018 | $1,655,000 | -32.9% | 50,667 | 0.0% | 0.01% | -28.6% |
| Q4 2017 | $2,466,000 | -9.9% | 50,667 | 0.0% | 0.01% | -12.5% |
| Q3 2017 | $2,738,000 | +28.3% | 50,667 | +33.3% | 0.01% | +14.3% |
| Q2 2017 | $2,134,000 | – | 38,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,220,672 | $55,602,000 | 9.30% |
| Fernwood Investment Management, LLC | 201,211 | $9,165,000 | 7.20% |
| Cormorant Asset Management, LP | 500,000 | $22,775,000 | 3.03% |
| Ghost Tree Capital, LLC | 170,000 | $7,744,000 | 2.51% |
| HARVEY CAPITAL MANAGEMENT INC | 155,030 | $7,108,000 | 2.40% |
| SECTORAL ASSET MANAGEMENT INC | 1,169,130 | $53,254,000 | 2.22% |
| Atika Capital Management LLC | 98,000 | $4,464,000 | 2.01% |
| Temasek Holdings (Private) Ltd | 5,833,568 | $265,719,000 | 1.66% |
| CABOT WEALTH MANAGEMENT INC | 124,309 | $5,662,000 | 1.38% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 314,689 | $14,334,000 | 1.11% |